These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 32412587)

  • 1. Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure.
    Reis FM; Coutinho LM; Vannuccini S; Batteux F; Chapron C; Petraglia F
    Hum Reprod Update; 2020 Jun; 26(4):565-585. PubMed ID: 32412587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometriosis and nuclear receptors.
    Yilmaz BD; Bulun SE
    Hum Reprod Update; 2019 Jul; 25(4):473-485. PubMed ID: 30809650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone resistance in endometriosis: link to failure to metabolize estradiol.
    Bulun SE; Cheng YH; Yin P; Imir G; Utsunomiya H; Attar E; Innes J; Julie Kim J
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):94-103. PubMed ID: 16406281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestin effects on expression of AKR1C1-AKR1C3, SRD5A1 and PGR in the Z-12 endometriotic epithelial cell line.
    Beranič N; Lanišnik Rižner T
    Chem Biol Interact; 2013 Feb; 202(1-3):218-25. PubMed ID: 23183084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone receptor ligands for the treatment of endometriosis.
    Clemenza S; Capezzuoli T; Eren E; Garcia Garcia JM; Vannuccini S; Petraglia F
    Minerva Obstet Gynecol; 2023 Jun; 75(3):288-297. PubMed ID: 36255163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen-induced stromal cell-derived factor-1 (SDF-1/Cxcl12) expression is repressed by progesterone and by Selective Estrogen Receptor Modulators via estrogen receptor alpha in rat uterine cells and tissues.
    Glace L; Grygielko ET; Boyle R; Wang Q; Laping NJ; Sulpizio AC; Bray JD
    Steroids; 2009; 74(13-14):1015-24. PubMed ID: 19665469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis.
    Grandi G; Mueller MD; Papadia A; Kocbek V; Bersinger NA; Petraglia F; Cagnacci A; McKinnon B
    J Reprod Immunol; 2016 Sep; 117():30-8. PubMed ID: 27371899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-196a overexpression activates the MEK/ERK signal and represses the progesterone receptor and decidualization in eutopic endometrium from women with endometriosis.
    Zhou M; Fu J; Xiao L; Yang S; Song Y; Zhang X; Feng X; Sun H; Xu W; Huang W
    Hum Reprod; 2016 Nov; 31(11):2598-2608. PubMed ID: 27619769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of AKT on progesterone action in endometrial diseases.
    Lee II; Kim JJ
    Biol Reprod; 2014 Sep; 91(3):63. PubMed ID: 25100707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone Resistance in Endometriosis: Current Evidence and Putative Mechanisms.
    Zhang P; Wang G
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal treatments for endometriosis: The endocrine background.
    Vannuccini S; Clemenza S; Rossi M; Petraglia F
    Rev Endocr Metab Disord; 2022 Jun; 23(3):333-355. PubMed ID: 34405378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting YAP1 ameliorates progesterone resistance in endometriosis.
    Lin SC; Li WN; Lin SC; Hou HT; Tsai YC; Lin TC; Wu MH; Tsai SJ
    Hum Reprod; 2023 Jun; 38(6):1124-1134. PubMed ID: 37071897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice.
    Liang B; Wu L; Xu H; Cheung CW; Fung WY; Wong SW; Wang CC
    Reprod Biol Endocrinol; 2018 Apr; 16(1):32. PubMed ID: 29615065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol.
    Zeitoun K; Takayama K; Sasano H; Suzuki T; Moghrabi N; Andersson S; Johns A; Meng L; Putman M; Carr B; Bulun SE
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4474-80. PubMed ID: 9851796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone Receptor Status Predicts Response to Progestin Therapy in Endometriosis.
    Flores VA; Vanhie A; Dang T; Taylor HS
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4561-4568. PubMed ID: 30357380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between progestins, nuclear receptors expression and inflammation in endometrial stromal cells from women with endometriosis.
    Grandi G; Mueller MD; Bersinger NA; Facchinetti F; McKinnon BD
    Gynecol Endocrinol; 2017 Sep; 33(9):712-715. PubMed ID: 28412861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Estrogen and progesterone cytosol receptor concentrations in patients with endometriosis and their changes after gossypol therapy].
    Zhang YW; Han ML; Wang YF
    Zhonghua Fu Chan Ke Za Zhi; 1994 Apr; 29(4):220-3, 253. PubMed ID: 8082445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research progress of dydrogesterone in the treatment of endometriosis.
    Tang W; Zhu X; Bian L; Zhang B
    Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():120-125. PubMed ID: 38430648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometriosis: the ultimate hormonal disease.
    Gurates B; Bulun SE
    Semin Reprod Med; 2003 May; 21(2):125-34. PubMed ID: 12917782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal therapy for endometriosis: from molecular research to bedside.
    Tosti C; Biscione A; Morgante G; Bifulco G; Luisi S; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2017 Feb; 209():61-66. PubMed ID: 27503693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.